COMMUNIQUÉS West-GlobeNewswire

Novartis International AG: Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®
28/05/2018
Overall summary score was also significantly higher for Entresto patients than for patients not taking Entresto, as measured by the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)[1] These improvements were [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2018
28/05/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 28, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial [...]
Novo Nordisk A/S - Share repurchase programme
28/05/2018
Bagsværd, Denmark, 28 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
28/05/2018
Company Announcement - No. 16/2018 Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia Last patient visit concluded in the multinational [...]
Mandatory notification of trade
28/05/2018
Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding the final result of the subsequent repair issue. Vegard Heggem, VP Operations, has been allocated 10,000 new shares at a [...]
Transactions under Novozymes’ stock buyback program
28/05/2018
Please read the full announcement in the attached PDF Attachment 2018_36_Stock_Buybackprogram_EN
Announcement by Heirs of Late Valerijs Maligins
28/05/2018
Announcement by Heirs of Late Valerijs Maligins JSC Olainfarm hereby informs that it has received the folowing announcement from heirs of Valerijs Maligins. Mutually Acceptable Agreement is Reached About Distribution of [...]
Solon Eiendom ASA : Primary insider notification
28/05/2018
(Oslo, Norway, May 25, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 30.000 shares in Solon Eiendom ASA at a price of NOK 28.7105. Following this [...]
Solon Eiendom ASA : Commencement of subscription period
28/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
PCI Biotech: Disclosure of voting rights for Chairman of the Board
28/05/2018
Oslo, 28 May 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual [...]
Vistin Pharma ASA : Final result of the subsequent repair issue
28/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Shire plc : Rule 2.9 Announcement
28/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 28 May 2018 Shire [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
28/05/2018
REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
28/05/2018
REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
28/05/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 28 May 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
28/05/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 28 mai 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]
Biocartis Group NV: Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests
28/05/2018
PRESS RELEASE : 28 May 2018, 07:00 CEST Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests Mechelen, Belgium, 28 May 2018 - [...]
CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
28/05/2018
OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 27, 2018 (GLOBE NEWSWIRE) -- CEPI—the Coalition for Epidemic Preparedness Innovations—today announced a collaboration with Profectus BioSciences, Inc. and Emergent [...]
Dentsply Sirona to Present at the Stifel 2018 Dental & Veterinary Conference on May 30th
27/05/2018
YORK, Pa., May 27, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY ), The Dental Solutions Company, today announced it will participate in the Stifel 2018 Dental & Veterinary [...]

Pages